Small-molecule CEM3 strengthens single-cell oscillators in the suprachiasmatic nucleus

被引:0
|
作者
van Beurden, Anouk W. [1 ]
Tersteeg, Mayke M. H. [1 ]
Michel, Stephan [1 ]
van Veldhoven, Jaco P. D. [2 ]
Ijzerman, Adriaan P. [2 ]
Rohling, Jos H. T. [1 ]
Meijer, Johanna H. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands
[2] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands
来源
FASEB JOURNAL | 2024年 / 38卷 / 01期
基金
欧洲研究理事会;
关键词
CEM3; PER2; rhythm amplitude; small molecule; suprachiasmatic nucleus; synchrony; CIRCADIAN-RHYTHMS; CLOCK; MODULATORS; NEURONS; MOUSE;
D O I
10.1096/fj.202300597RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A robust endogenous clock is required for proper function of many physiological processes. The suprachiasmatic nucleus (SCN) constitutes our central circadian clock and allows us to adapt to daily changes in the environment. Aging can cause a decline in the amplitude of circadian rhythms in SCN and peripheral clocks, which contributes to increased risk of several chronic diseases. Strengthening clock function would therefore be an effective strategy to improve health. A high-throughput chemical screening has identified clock-enhancing molecule 3 (CEM3) as small molecule that increases circadian rhythm amplitude in cell lines and SCN explants. It is, however, currently not known whether CEM3 acts by enhancing the amplitude of individual single-cell oscillators or by enhancing synchrony among neurons. In view of CEM3's potential, it is of evident importance to clarify the mode of action of CEM3. Here, we investigated the effects of CEM3 on single-cell PERIOD2::LUCIFERASE rhythms in mouse SCN explants. CEM3 increased the amplitude in approximately 80%-90% of the individual cells in the SCN without disrupting the phase and/or period of their rhythms. Noticeably, CEM3's effect on amplitude is independent of the cell's initial amplitude. These findings make CEM3 a potential therapeutic candidate to restore compromised amplitude in circadian rhythms and will boost the development of other molecular approaches to improve health. Circadian rhythms are generated by the suprachiasmatic nucleus (SCN). Disruption of rhythms is a causal risk factor for the development of diseases, like depression or immune disorders. The small-molecule CEM3 strengthens SCN rhythms by enhancement of amplitude. We asked whether amplitude enhancement is a single-cell or a network phenomenon. The results indicate that CEM3 operates by increasing the amplitude of individual SCN neurons. This makes CEM3 an interesting therapeutic candidate for improving health by strengthening our internal clock.image
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Small-molecule labeling of live cell surfaces for 3D super-resolution microscopy
    Lee, Marissa K.
    Rai, Prabin
    Williams, Jarrod
    Twieg, Robert J.
    Moerner, W. E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [22] Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer
    Lewis, Katherine M.
    Bharadwaj, Uddalak
    Eckols, T. Kris
    Kolosov, Mikhail
    Kasembeli, Moses M.
    Fridley, Colleen
    Siller, Ricardo
    Tweardy, David J.
    LUNG CANCER, 2015, 90 (02) : 182 - 190
  • [23] Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer
    Xiao, Han
    Zhao, Rong
    Meng, Wangyang
    Liao, Yongde
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2023, 13 (06) : 625 - 639
  • [24] Small Molecule Injection into Single-Cell C. elegans Embryos via Carbon-Reinforced Nanopipettes
    Brennan, Lucy D.
    Roland, Thibault
    Morton, Diane G.
    Fellman, Shanna M.
    Chung, SueYeon
    Soltani, Mohammad
    Kevek, Joshua W.
    McEuen, Paul M.
    Kemphues, Kenneth J.
    Wang, Michelle D.
    PLOS ONE, 2013, 8 (09):
  • [25] Small-molecule cyclic αVβ3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion
    Finnegan, Eileen M.
    Barabino, Gilda A.
    Liu, Xiao-du
    Chang, Hee-Yoon
    Jonczyk, Alfred
    Kaul, Dhananjay K.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (02): : H1038 - H1045
  • [26] Identification of a small-molecule inhibitor of class la PI3Ks with cell-based screening
    Yang, Jiong
    Shamji, Alykhan
    Matchacheep, Sirinya
    Schreiber, Stuart L.
    CHEMISTRY & BIOLOGY, 2007, 14 (04): : 371 - 377
  • [27] Suppression of Hepatic Stellate Cell Activation by HJC0123, a Novel Small-Molecule Inhibitor of STAT3
    Bohanon, Fredrick
    Wang, Xiaofu
    Lopez, Omar Nunez
    Vasudevan, Sadhashiva
    Chen, Haijun
    Zhou, Jia
    Radhakrishnan, Ravi
    GASTROENTEROLOGY, 2016, 150 (04) : S1259 - S1259
  • [28] Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro
    Chen, Xiaodie
    Lu, Zhen
    Xiao, Jin
    Xia, Wei
    Pan, Yi
    Xia, Houjun
    Chen, Youhai H.
    Zhang, Haiping
    CELLS, 2024, 13 (09)
  • [29] High content screen for identifying small-molecule LC3B-localization modulators in a renal cancer cell line
    Likhitha Kolla
    David S. Heo
    Daniel P. Rosenberg
    Sara A. Barlow
    Anna A. Maximova
    Emily E. Cassio
    William J. Buchser
    Scientific Data, 5
  • [30] Microarray-Assisted High-Throughput Identification of a Cell-Permeable Small-Molecule Binder of 14-3-3 Proteins
    Wu, Hao
    Ge, Jingyan
    Yao, Shao Q.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (37) : 6528 - 6532